The MiniMed™ 770G system
An insulin pump and CGM (continuous glucose monitoring) system that automatically adjusts insulin delivery every 5 minutes, to help prevent highs and lows.*
Get the rest your body needs with features that can help make managing diabetes easier.
Predicts
Monitors your glucose levels 24/7 and predicts whether you’re going high or low.
Adapts
Continuously adapts to your needs based on your real-time data and personal trends.
Self-adjusts
Smooths out highs and lows, with SmartGuard™ tech that increases or decreases insulin delivery, every 5 minutes.*
Connects
View, share, and automatically upload your insulin and continuous glucose monitor (CGM) data directly from your smartphone.
SmartGuard™ tech adapts to your unique needs
An integrated system - meaning a pump and CGM that speak to each other
The pump gets sugar readings from the CGM and then automatically delivers a variable rate of insulin 24 hours a day based on your personal need.*
Real people. Real experiences.
Thoughts and opinions are his own. Individual results may vary.
Compensated for his time. Thoughts and opinions are his own. Individual results may vary.
Support every step of the way
As your partner in care, we are here to help wherever you are on your diabetes journey.
Help choosing the right therapy
Assistance
programs^
Hands-on product
training
24-Hour Technical
Support
Online educational
resources
Clinical
supportΦ
Frequently asked questions
The MiniMed™ 770G system is approved for people with type 1 diabetes ages 2 and above. To learn more about insulin pump therapy for children please click here. If you are considering using only an insulin pump, the MiniMed™ 630G system with optional CGM may be a better fit. If you are considering using only CGM, consider the Guardian™ Connect CGM system.
Medtronic insulin pumps are covered by most insurance plans. Your out-of-pocket cost varies depending on your insurance. We also offer financial assistance and monthly payment programs to those purchasing a new device. Terms and conditions apply.
Yes, using the system does not completely replace fingersticks. Readings from a blood glucose meter are required to calibrate the sensor 2-4 times a day to make sure the glucose sensor maintains accuracy over time and always when making a treatment decision.
When you use an insulin pump, you have a dramatic reduction in injections – by up to 90%*. The infusion set that attaches to your body contains a small, flexible cannula that is inserted to be placed under the skin and changed every 2-3 days. A CGM glucose sensor is inserted up to 7 days.
* Assumes four injections per day for 30 days and one infusion set change every two to three days.
* Refers to SmartGuard™ Auto Mode. Some user interaction required. Individual results may vary.
^ Terms and conditions apply.
Φ Not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Software Upgrade Terms and Conditions:
- This program allows MiniMed™ 770G system users a software upgrade at no charge within one year from the date of this software approval. Software approval will be announced.
- Software upgrade process is subject to change. The process may result in healthcare provider office visit and may result in out-of-pocket expenses such as co-pay, depending on insurance coverage. The process may require the completion of product related training.
- This program includes the insulin pump software only. CGM products and consumables are not included in this offer.
- Warranty dates do not reset. The replacement warranty date of an insulin pump upgraded with the software will remain the same as the replacement warranty date of the initial pump purchased. Your warranty date does not impact eligibility for a software update.
- MiniMed™ pumps and software have certain labeling restrictions that may exclude certain populations, including age and type of diabetes. We recommend you consult your healthcare provider regarding your eligibility to receive the software upgrade based on the labeling of the upgrade, which may differ from the labeling of the MiniMed™ 770G pump.
- Insurance coverage and plan design varies and may impact the ability to upgrade. Coverage is contingent upon your health insurance medical policy guidelines. Restrictions and medical necessity requirements may apply.
- A valid prescription will be required for this software upgrade. All participants should consult their healthcare provider for all therapy related decisions.
- Program terms and conditions are subject to change at any time and without notice. Other restrictions may apply.
Important Safety Information: MiniMed™ 770G System With SmartGuard™ Technology
The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G System includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.
The Medtronic MiniMed™ 770G System consists of the following devices: MiniMed™ 770G Insulin Pump, the Guardian™ Link (3) Transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the AccuChek®Guide Test Strips. The system requires a prescription.
The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).
All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.
WARNING: Do not use the SmartGuard™ Auto Mode for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in SmartGuard™ Auto Mode.
WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.
Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safetyinformation#minimed-770g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library